The Azur Selection Intends to Acquire Latin Beach, a Front-Beach Site on the Athenian Riviera
The Azur Selection (ISIN : GRS528003007 - Mnémonique : MLAZR), a Greek hotel company listed on the Euronext Access + market in Paris, announces the project of acquisition of Latin Beach.
Business Wire19h
BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission
BenevolentAI (“the Company”), a pioneer in integrating artificial intelligence with biopharmaceutical development, today ...
Voting Rights and Shares Capital of the Company
II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des ...
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc (CRN) Cairn Homes Plc: Transaction in Own Shares 11-Dec-2024 / 07:00 GMT/BST ...
Publicis Groupe Announces Global Expansion of LePub
PUBLICIS GROUPE ANNOUNCES GLOBAL EXPANSION OF LEPUBAcclaimed creative network to strategically launch in key markets; ...
The Pharma Letter18h
Positive leniolisib top-line data in pediatric clinical trial from Pharming
Netherlands-based Pharming Group today released positive top-line results of data from its Phase III clinical trial ...
The Pharma Letter18h
NewAmsterdam leaps on positive trial results
Dutch clinical-stage drug developer NewAmsterdam Pharma saw its shares close up 41% at $26.19 yesterday on positive research ...
Business Wire19h
Electrical Grid Operator Red Eléctrica Transforms Its Design Process and Collaboration with Dassault Systèmes’ 3DEXPERIENCE Platform
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Red Eléctrica, the transmission system operator (TSO) of Spain’s high vo ...
pharmaphorum16h
Mulvany hits the reset button at BenevolentAI
Mulvany – who left BenevolentAI when it listed on the Amsterdam stock exchange in 2022 and retains a sizeable stake in the ...
Taiwan News12h
OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®
NANTES, France, December 11, 2024 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today provided a clinical update on Tedopi® (OSE-2101), the ‘off-the-shelf’ ...
PharmiWeb18h
Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US
The US Food and Drug Administration has granted Fast Track designation to two Sanofi combination vaccine candidates to prevent influenza and COVID-19 infections in individuals 50 years of age and ...